Sfoglia per Autore
Gli antidoti in Oncologia medica: efficacia, costo e beneficio
1998-01-01 Mustacchi, Giorgio
Carcinoma dell’ovaio
1998-01-01 Mustacchi, Giorgio; V., Amoroso; R., Ceccherini; M., Muggia
Sequential Tamoxifen and Aminoglutethimide Versus Tamoxifen Alone in the Adjuvant Treatment of Postmenopausal Breast cancer Patients: Results of an Italian Cooperative Study
2001-01-01 F., Boccardo; A., Rubagotti; D., Amoroso; M., Mesiti; D., Romeo; C., Caroti; A., Farris; G., Cruciani; E., Villa; Mustacchi, Giorgio
A Phase II study of cisplatin and vinorelbine in patients with metastatic breast cancer.
2002-01-01 Mustacchi, Giorgio; M., Muggia; S., Milani; R., Ceccherini; ML LEITA AND C., Dellach
Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long term results of the phase III randomized controlled multicenter “GRETA” trial.
2003-01-01 Mustacchi, Giorgio; R., Ceccherini; S., Milani; A., Pluchinotta; A., DE MATTEIS; L., Maiorino; A., Farris; A. SCANNI AND F., Sasso
Role of erythropoietin in the oncology patient: critical review of the literature
2005-01-01 Mustacchi, Giorgio
La metanalisi di Oxford del 2000: riflessioni e commenti
2005-01-01 Mustacchi, Giorgio
Prevention of chemotherapy-induced early menopause in early breast cancer patients. A phase III multicenter study of GIM Group
2006-01-01 Delmastro, L; Michelotti, A; Mustacchi, Giorgio
Factors influencing the switch from tamoxifen to aromatase inhibitors as adjuvant therapy in early breast cancer patients. Results from the NORA Study
2006-01-01 P., Pronzato; Me, Cazzaniga; Mustacchi, Giorgio
Adjuvant systemic treatment of early breast cancer: The NORA study.
2006-01-01 Cazzaniga, Me; Mustacchi, Giorgio; Pronzato, P.
An induction dose of epoietin alpha of 40.000 IU daily for three consecutive days increases and mantains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
2006-01-01 Mustacchi, Giorgio; R., Ceccherini; C., Dellach; S., Foladore; S., Milani; M. LEITA AND M., Sisto
Molecular targets of cancer chemotherapy
2006-01-01 K. S., Zaenker; Mustacchi, Giorgio; AND E., Mihich
Annual Hazard Rates of Recurrence for early breast cancer. What has changed in the last 10 years? Results from the NORA study.
2007-01-01 Cazzaniga, Me; Mustacchi, Giorgio; Pronzato, P.
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma: pooled analysis of 2 consecutive trials.
2007-01-01 Boccardo, F; Rubagotti, A; Aldrighetti, D; Buzzi, F; Cruciani, G; Farris, A; Mustacchi, Giorgio; Porpiglia, M; Schieppati, G; Sismondi, P.
Adjuvant treatment of early breast cancer: do the St Gallen recommendations influence clinical practice? Results from the NORA study
2007-01-01 M. E., Cazzaniga; Mustacchi, Giorgio; P., Pronzato; A., DE MATTEIS; F., DI COSTANZO; AND I., FLORIANI ON BEHALF OF THE NORA STUDY GROUP
Breast cancer in elderly women: a different reality? Results from the NORA Study
2007-01-01 M. E., Cazzaniga; P., Pronzato; A., DE MATTEIS; F., DI COSTANZO; Mustacchi, Giorgio
The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database
2008-01-01 Lg, Mantovani; A., Morsanutto; F., Tosolini; Mustacchi, Giorgio
The anthracyclines and the clinical practice: do all breast cancer patients benefit? Results from the NORA study.
2008-01-01 M. E., Cazzaniga; Mustacchi, Giorgio
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score
2008-01-01 Ménard, S; Balsari, A; Tagliabue, E; Camerini, T; Casalini, P; Bufalino, R; Castiglioni, F; Carcangiu, Ml; Gloghini, A; Scalone, S; Querzoli, P; Lunardi, M; Molino, A; Mandarã, M; Mottolese, M; Marandino, F; Venturini, M; Bighin, C; Cancello, G; Montagna, E; Perrone, F; DE MATTEIS, A; Sapino, A; Donadio, M; Battelli, N; Santinelli, A; Pavesi, L; Lanza, A; Zito, Fa; Labriola, A; Aiello, Ra; Caruso, M; Zanconati, Fabrizio; Mustacchi, Giorgio; Barbareschi, M; Frisinghelli, M; Russo, R; Carrillo, G; Omero, Group
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study
2009-01-01 Mustacchi, Giorgio; Mansutti, M; Sacco, C; Barni, S; Farris, A; Cazzaniga, M; Cozzi, M; Dellach, C.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile